Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest Articles"Tapentadol" - A Novel Analgesic
Journal of Anaesthesiology Clinical Pharmacology, 10/05/09
Tayal G et al. – Tapentadol is a new analgesic drug with a dual mode of action, hence has efficacy in a broad spectrum of acute and chronic pain models and possibly an improved tolerability profile. It combines moderate mu–opioid agonist activity with NE reuptake inhibition in a single, nonracemic molecule. No metabolic activation of tapentadol is necessary for analgesia, and it has no active metabolites. Further RCTs are needed to establish its routine use in postoperative patients.
Related Articles
Tapentadol immediate release for the relief of moderate-to-severe acute pain
Expert Opinion in Pharmacotherapy, 10/08/09
Relevance Score: 92%
Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single molecule
Drugs of Today, 10/19/09
Relevance Score: 90%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Mode of arrival does not predict myocardial infarction in patients who present to the ED with chest pain
International Journal of Emergency Medicine, 11/25/09
How triggers trigger acute migraine attacks: A hypothesis
Medical Hypotheses, 11/23/09
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09
Article Search
Sponsor